MIKEL
TAINTA CUEZVA
VU University Medical Center
Ámsterdam, HolandaPublikationen in Zusammenarbeit mit Forschern von VU University Medical Center (19)
2023
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999
2021
-
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia
Alzheimer's and Dementia, Vol. 17, Núm. 3, pp. 500-514
-
Differential early subcortical involvement in genetic FTD within the GENFI cohort
NeuroImage: Clinical, Vol. 30
-
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 6, pp. 608-616
-
Replication study of plasma proteins relating to Alzheimer's pathology
Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464
-
Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
Biomedicines, Vol. 9, Núm. 11
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
2020
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
-
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 3
-
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort
Cortex, Vol. 133, pp. 384-398
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225
2019
-
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938
-
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Alzheimer's and Dementia, Vol. 15, Núm. 5, pp. 644-654
-
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Alzheimer's and Dementia, Vol. 15, Núm. 11, pp. 1478-1488
-
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia
Neurobiology of Aging, Vol. 77, pp. 169-177
-
Inflammatory biomarkers in Alzheimer's disease plasma
Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 776-787